117 related articles for article (PubMed ID: 6096462)
1. [Endocrine profile and electron microscopic study of ovarian androblastoma].
Inoue S; Fukuda O; Koyama N; Furuki Y; Munemura M; Maeyama M; Mizumoto J; Miyayama Y
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1155-62. PubMed ID: 6096462
[TBL] [Abstract][Full Text] [Related]
2. Endocrine profile of an ovarian androblastoma.
Munemura M; Nakamura T; Matsuura K; Maeyama M; Iwamasa T
Obstet Gynecol; 1982 Jun; 59(6 Suppl):100S-4S. PubMed ID: 6283443
[TBL] [Abstract][Full Text] [Related]
3. Endocrine studies on ovarian androblastomas (Sertoli-Leydig tumors).
Munemura M; Inoue S; Himeno R; Koyama N; Mizumoto J; Maeyama M; Iwamasa T
J Endocrinol Invest; 1984 Dec; 7(6):615-22. PubMed ID: 6099378
[TBL] [Abstract][Full Text] [Related]
4. Mucinous adenofibroma of the ovary: case report of the endocrinologic findings.
Tohya T; Mizutani H; Katabuchi H; Miyazaki K; Okamura H
Gynecol Oncol; 1994 Aug; 54(2):218-21. PubMed ID: 8063250
[TBL] [Abstract][Full Text] [Related]
5. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.
Wiebe RH; Morris CV
Obstet Gynecol; 1983 Mar; 61(3):279-84. PubMed ID: 6296743
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and resection of an oral contraceptive-suppressible Sertoli-Leydig cell tumor with preservation of fertility and a 7-year follow-up.
Haning RV; Loughlin J; Shapiro SS
Obstet Gynecol; 1989 May; 73(5 Pt 2):901-5. PubMed ID: 2523030
[TBL] [Abstract][Full Text] [Related]
7. Peripheral and ovarian venous concentrations of various steroid hormones in virilizing ovarian tumors.
Meldrum DR; Abraham GE
Obstet Gynecol; 1979 Jan; 53(1):36-43. PubMed ID: 215947
[TBL] [Abstract][Full Text] [Related]
8. Malignant ovarian Sertoli-Leydig cell tumor localized with selective ovarian vein sampling.
Dunne C; Havelock JC
J Minim Invasive Gynecol; 2012; 19(6):789-93. PubMed ID: 23084689
[TBL] [Abstract][Full Text] [Related]
9. Virilising ovarian tumour: a case associating a Sertoli-Leydig cell tumour and a Brenner tumour.
Persechini ML; Motton S; Leguevaque P; Donadille F; Escourrou G; Vierasu B; Hamdi S; Bennet A; Caron P
Gynecol Endocrinol; 2011 May; 27(5):345-50. PubMed ID: 20569103
[TBL] [Abstract][Full Text] [Related]
10. The hormone pattern in a case of arrhenoblastoma.
Toscano V; Adamo MV; Boscherini B; Pasquino AM; Herlitzka L; Petrangeli E; Sciarra F
Eur J Pediatr; 1981 May; 136(2):203-6. PubMed ID: 6262084
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical and biochemical analysis of a human Sertoli-Leydig cell tumor: autonomous steroid production characteristic of ovarian theca cells.
Sawetawan C; Rainey WE; Word RA; Carr BR
J Soc Gynecol Investig; 1995; 2(1):30-7. PubMed ID: 9420846
[TBL] [Abstract][Full Text] [Related]
12. Selective ovarian vein sampling can be crucial to localize a Leydig cell tumor: an unusual case in a postmenopausal woman.
Ozgun MT; Batukan C; Turkyilmaz C; Dolanbay M; Mavili E
Maturitas; 2008 Nov; 61(3):278-80. PubMed ID: 18930614
[TBL] [Abstract][Full Text] [Related]
13. Sertoli-Leydig cell tumor of the ovary, with an associated mucinous cystadenoma. An ultrastructural and endocrine study.
Roth LM; Cleary RE; Rosenfield RL
Lab Invest; 1974 Dec; 31(6):648-57. PubMed ID: 4280005
[No Abstract] [Full Text] [Related]
14. Sertoli-Leydig cell tumor presenting hyperestrogenism in a postmenopausal woman: a case report and review of the literature.
Guo L; Yang X; Zhu H; Qiu W; Shi X; Huang B; Duan T
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):620-4. PubMed ID: 23276568
[TBL] [Abstract][Full Text] [Related]
15. [Morphological and endocrinological study of ovarian arrhenoblastoma (author's transl)].
Takakura K; Okamura H; Aso T; Takenaka A; Matsuoka M; Kanzaki H; Suzuki A; Nishimura T
Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):961-8. PubMed ID: 6272528
[TBL] [Abstract][Full Text] [Related]
16. Hormone levels following wedge resection in polycystic ovary syndrome.
Mahesh VB; Toledo SP; Mattar E
Obstet Gynecol; 1978 Jan; 51(1 Suppl):64s-69s. PubMed ID: 144874
[TBL] [Abstract][Full Text] [Related]
17. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and hormonal characteristics in a case of ovarian arrhenoblastoma.
Tita P; Spina A; Briguglia G; Magro A; Gallo D; Finocchiaro C; Padova G; Pezzino V
J Endocrinol Invest; 1996; 19(7):484-7. PubMed ID: 8884544
[TBL] [Abstract][Full Text] [Related]
19. Role of dehydroepiandrosterone sulfate as a prehormone for ovarian steroidogenesis.
Haning RV; Austin CW; Carlson IH; Kuzma DL; Zweibel WJ
Obstet Gynecol; 1985 Feb; 65(2):199-205. PubMed ID: 3155830
[TBL] [Abstract][Full Text] [Related]
20. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
